IP Library Granted Patent US 7,776,842
Granted Patent B2
US 7,776,842 · App. 11/466,701 · Granted Aug 17, 2010

Amino sugar chelates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,776,842
App. No.
11/466,701
Granted
Aug 17, 2010
Kind
B2
Abstract

The present invention includes amino sugar chelates and methods for preparing amino sugar chelates of the formula given below, where M is a metal; R 2 and R 3 are independently selected from H, OH and hydroxyl substituted C 1 -C 8 alkyl; R 4 is selected from H, CO 2 H, OH, and hydroxyl substituted C 1 -C 8 alkyl; each R 5 is independently selected from H, OH, and hydroxyl substituted C 1 -C 8 alkyl; A is selected from CH and O; a is from 0-6; b is from 0-6; n is from 1 to 8. The amino sugar chelates may include matrix stabilizing salts. The compounds and compositions disclosed can be used as nutritional supplements to impart health benefits.

Claims (30)

1. A compound of the formula:

wherein M is a nutritionally acceptable metal, R 2 and R 3 are independently selected from H, OH and hydroxyl substituted C 1 -C 8 alkyl, R 4 is selected from H, CO 2 H, OH, and hydroxyl substituted C 1 -C 8 alkyl, each R 5 is independently selected from H, OH, hydroxyl substituted C 1 -C 8 alkyl, or absent, A is selected from CH and O, a is from 1-6, b is from 1-6, n is from 1 to 8, wherein M is a nonferrous metal.

2. A compound of the formula:

wherein M is a nutritionally acceptable metal, R 2 and R 3 are independently selected from H, OH, and hydroxyl substituted C 1 -C 8 alkyl, R 4 is selected from H, CO 2 H, OH, and hydroxyl substituted C 1 -C 8 alkyl, each R 5 is independently selected from H, OH, NH 2 , and hydroxyl substituted C 1 -C 8 alkyl, a is from 1-6, b is from 1-6, n is from 1 to 8, wherein M is a nonferrous metal and wherein only one R 5 is NH 2 .

3. A compound of claim 1 , wherein M is selected from the group consisting of magnesium, calcium, copper, zinc, chromium, cobalt, molybdenum, selenium, and manganese.

4. A compound of claim 1 , wherein M is manganese.

5. A compound of claim 1 , wherein R 2 and R 3 are independently selected from H and OH.

6. A compound of claim 1 , wherein a is 2.

7. A compound of claim 1 , wherein M is a manganese, each R 2 is OH, each R 3 is H, R 4 is CH 2 CH 2 OH, R 5 is independently selected from H, OH, hydroxyl substituted C 1 -C 8 alkyl, or absent, each A is independently selected from CH, CH 2 and O, a is from 1-6, b is from 1-6 and n is 3.

8. An amino sugar chelate comprising one or more amino sugar ligands, one or more saturated hydroxylated carboxylic acid ligands, and a nutritionally acceptable metal, wherein at least one of the one or more amino sugar ligands is glucosamine, and wherein the metal is manganese, and wherein the one or more saturated hydroxylated carboxylic acid ligands is gluconic acid, and wherein the glucosamine ligand to manganese ratio is 2:1, wherein the nutritionally metal is nonferrous.

9. An amino sugar chelate comprising one or more amino sugar ligands, one or more saturated hydroxylated carboxylic acid ligands, and a nutritionally acceptable metal, wherein the ligand to metal molar ratio is from 2:1 to 4:1, wherein the amino sugar chelate is defined by the formula:

(C 6 H 13 NO 5 ) b M(C 6 H 12 O 7 ) a , wherein a is from 1 to 6, and b is from 1 to 6, wherein the nutritionally acceptable metal is nonferrous.

10. The amino sugar chelate of claim 9 , wherein a is 1 and b is 2.

11. The amino sugar chelate of claim 9 , wherein a is 2 and b is 2.

12. A composition comprising a compound of the formula:

wherein M is a nutritionally acceptable metal, R 2 and R 3 are independently selected from H, OH and hydroxyl substituted C 1 -C 8 alkyl, R 4 is selected from H, CO 2 H, OH, and hydroxyl substituted C 1 -C 8 alkyl, each R 5 is independently selected from H, OH, hydroxyl substituted C 1 -C 8 alkyl, or absent, A is selected from CH and O, a is from 1-6, b is from 1-6, n is from 1 to 8;

a stabilizing matrix salt;

chondroitin; wherein M is nonferrous.

13. A composition comprising a compound of the formula:

wherein M is a nutritionally acceptable metal, R 2 and R 3 are independently selected from H, OH and hydroxyl substituted C 1 -C 8 alkyl, R 4 is selected from H, CO 2 H, OH, and hydroxyl substituted C 1 -C 8 alkyl, each R 5 is independently selected from H, OH, hydroxyl substituted C 1 -C 8 alkyl, or absent, A is selected from CH and O, a is from 1-6, b is from 1-6, n is from 1 to 8;

a stabilizing matrix salt;

vitamin C; wherein M is nonferrous.

14. A composition comprising a compound of the formula:

wherein M is a nutritionally acceptable metal, R 2 and R 3 are independently selected from H, OH, and hydroxyl substituted C 1 -C 8 alkyl, R 4 is selected from H, OH, CO 2 H, and hydroxyl substituted C 1 -C 8 alkyl, each R 5 is independently selected from H, OH, hydroxyl substituted C 1 -C 8 alkyl, or absent, each A is independently selected from CH, CH 2 and O, a is from 1-6, b is from 1-6, n is independently from 0 to 8, and a stabilizing matrix salt, wherein M is nonferrous.

15. The composition of claim 12 , wherein M is selected from one or more of the group consisting of magnesium, calcium, copper, zinc, chromium, cobalt, molybdenum, selenium, and manganese.

16. The composition of claim 12 , wherein M is manganese.

17. The composition of claim 12 , wherein R 2 and R 3 are independently selected from H and OH.

18. The composition of claim 12 , wherein a is 2.

19. The composition of claim 12 , further comprising chondroitin.

20. The composition of claim 12 , further comprising vitamin C.

Assignments (5)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jun 29, 2018
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: ALBION LABORATORIES, INC.
Reel/Frame 046464/0708 →
SECURITY INTEREST Recorded Jun 27, 2018
From: ALBION LABORATORIES, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 046221/0237 →
MERGER AND CHANGE OF NAME Recorded Jan 30, 2017
From: ALBION INTERNATIONAL, INC.; ALBION HUMAN NUTRITION (DBA); ALBION LABORATORIES, INC.
To: ALBION LABORATORIES, INC.
Reel/Frame 041117/0178 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded May 4, 2016
From: ALBION LABORATORIES, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 038605/0824 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2006
From: ERICSON, CLAYTON; ASHMEAD, DEWAYNE; ASHMEAD, STEPHEN D; REES, AMANDA
To: ALBION LABORATORIES, INC.
Reel/Frame 018212/0033 →